BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36675485)

  • 1. The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study.
    Giannouli A; Efthymiou V; Konidari M; Mani I; Aravantinos L; Dourakis SP; Antoniou A; Deligeoroglou E; Bacopoulou F
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis in women with polycystic ovary syndrome.
    Hong X; Guo Z; Yu Q
    BMC Endocr Disord; 2023 Sep; 23(1):207. PubMed ID: 37752440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Song DK; Jung H; Jeong K; Chung H; Lee H
    Sci Rep; 2023 Aug; 13(1):13397. PubMed ID: 37591864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
    Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
    J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center.
    Taranto DOL; Guimarães TCM; Couto CA; Cândido AL; Azevedo RCS; Mattos FS; Elias MLC; Reis FM; Rocha ALL; Faria LC
    Arch Endocrinol Metab; 2020; 64(3):235-242. PubMed ID: 32555989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.
    Cai J; Wu CH; Zhang Y; Wang YY; Xu WD; Lin TC; Li SX; Wang LH; Zheng J; Sun Y; Liu W; Tao T
    Int J Obes (Lond); 2017 Sep; 41(9):1341-1347. PubMed ID: 28487551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome.
    Wang D; Nan N; Bing H; He B
    Front Endocrinol (Lausanne); 2023; 14():1241734. PubMed ID: 37720537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome.
    Chakraborty S; Ganie MA; Masoodi I; Jana M; ; Gupta N; Sofi NY
    Indian J Med Res; 2020 Apr; 151(4):333-341. PubMed ID: 32461397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
    Bohdanowicz-Pawlak A; Lenarcik-Kabza A; Brona A; Kuliczkowska-Płaksej J; Łaczmański Ł; Zaleska-Dorobisz U; Milewicz A
    Endokrynol Pol; 2014; 65(6):416-21. PubMed ID: 25554608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.
    Petta S; Ciresi A; Bianco J; Geraci V; Boemi R; Galvano L; Magliozzo F; Merlino G; Craxì A; Giordano C
    PLoS One; 2017; 12(11):e0186136. PubMed ID: 29161258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vryonidou A; Ioannidis D; Kosma L; Katsoulis K; Papavassiliou E; Tzavara I
    Hum Reprod; 2010 Jan; 25(1):212-20. PubMed ID: 19887498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome.
    Patel-Sanchez N; Perito E; Tsai P; Raymond-Flesch M; Lodish M; Sarkar M
    J Pediatr Endocrinol Metab; 2023 May; 36(5):441-446. PubMed ID: 37060356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease.
    Kim JJ; Kim D; Yim JY; Kang JH; Han KH; Kim SM; Hwang KR; Ku SY; Suh CS; Kim SH; Choi YM
    Aliment Pharmacol Ther; 2017 Jun; 45(11):1403-1412. PubMed ID: 28370150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.
    Zhang J; Hu J; Zhang C; Jiao Y; Kong X; Wang W
    Exp Ther Med; 2018 May; 15(5):4259-4264. PubMed ID: 29725371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.
    Rocha ALL; Faria LC; Guimarães TCM; Moreira GV; Cândido AL; Couto CA; Reis FM
    J Endocrinol Invest; 2017 Dec; 40(12):1279-1288. PubMed ID: 28612285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatic steatosis in women with polycystic ovary syndrome.
    Karoli R; Fatima J; Chandra A; Gupta U; Islam FU; Singh G
    J Hum Reprod Sci; 2013 Jan; 6(1):9-14. PubMed ID: 23869143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome.
    Kara O; Arsoy HA; Keskin M
    Clin Exp Pediatr; 2023 Sep; 66(9):395-402. PubMed ID: 37321582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.